Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Verhagen NE, Touw DCW, van den Heuvel JJMW, van den Broek PH, et al. Characterizing P-glycoprotein and Breast Cancer Resistance Protein interactions of asciminib among other tyrosine kinase inhibitors used in chronic myeloid leukemia. Cancer Chemother Pharmacol 2026;96:47.
PMID: 42118353


Privacy Policy